Gliosarcoma of Brain
4 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Intrathecal Azacitidine and Nivolumab in Patients With Recurrent High-grade Glioma (NCT06896110) | Andrew P. Groves | 2025-06-05 |
| A Phase IB 2 Dose Trial of IRS-1 HSV C134 (IND 17296) Administered Intratumorally in Patients With Recurrent Malignant Glioma (NCT06614855) | James Markert, MD | 2025-06-02 |
| Re-Administration of C134 in Patients With Recurrent GBM (C134-HSV-1) (NCT06193174) | University of Alabama at Birmingham | 2024-06-21 |
| Trial of C134 in Patients With Recurrent GBM (NCT03657576) | University of Alabama at Birmingham | 2019-09-23 |
Track Gliosarcoma of Brain automatically
Every clearance here is in the API, with alerts when new ones post.